Literature DB >> 17054673

Elevation of serum high-mobility group box 1 protein during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilisation.

Kozo Tagami1, Toshiaki Yujiri, Atsuko Tanimura, Noriyuki Mitani, Yukinori Nakamura, Koichi Ariyoshi, Toshihiko Ando, Yasuhiko Fujii, Yukio Tanizawa.   

Abstract

High mobility group box 1 (HMGB1) is a non-histone protein involved in maintaining the architecture of chromatin. HMGB1 also acts extracellularly as a cytokine, in processes such as inflammation, cell migration and stem cell recruitment. The involvement of HMGB1 in granulocyte colony-stimulating factor (G-CSF)-induced mobilisation of haematopoietic stem cells was investigated in 21 healthy donors. G-CSF treatment significantly elevated serum HMGB1 levels, which increased from 1.16 +/- 0.86 ng/ml, before treatment, to 31.1 +/- 5.99 ng/ml, after treatment. These findings suggest HMGB1 may play a role during the mobilisation of stem cells from the bone marrow into the systemic circulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17054673     DOI: 10.1111/j.1365-2141.2006.06335.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

Review 1.  Effects and safety of granulocyte colony-stimulating factor in healthy volunteers.

Authors:  Paolo Anderlini
Journal:  Curr Opin Hematol       Date:  2009-01       Impact factor: 3.284

2.  HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like inflammation in murine nonalcoholic fatty liver disease.

Authors:  Varun Chandrashekaran; Ratanesh K Seth; Diptadip Dattaroy; Firas Alhasson; Jacek Ziolenka; James Carson; Franklin G Berger; Balaraman Kalyanaraman; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Redox Biol       Date:  2017-05-10       Impact factor: 11.799

Review 3.  High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies.

Authors:  Shunling Yuan; Zhaoping Liu; Zhenru Xu; Jing Liu; Ji Zhang
Journal:  J Hematol Oncol       Date:  2020-07-13       Impact factor: 17.388

4.  Potentiation of NMDA receptor-dependent cell responses by extracellular high mobility group box 1 protein.

Authors:  Marco Pedrazzi; Monica Averna; Bianca Sparatore; Mauro Patrone; Franca Salamino; Manuela Marcoli; Guido Maura; Chiara Cervetto; Daniela Frattaroli; Sandro Pontremoli; Edon Melloni
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

5.  Relationship between HMGB1 and PAI-1 after allogeneic hematopoietic stem cell transplantation.

Authors:  Shosaku Nomura; Yoshinobu Maeda; Kazuyoshi Ishii; Yuta Katayama; Hideo Yagi; Naoto Fujishima; Shuichi Ota; Masato Moriyama; Takayuki Ikezoe; Yasuhiko Miyazaki; Kunio Hayashi; Shinya Fujita; Atsushi Satake; Tomoki Ito; Taiichi Kyo; Mitsune Tanimoto
Journal:  J Blood Med       Date:  2016-01-18

Review 6.  Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives.

Authors:  Tomomi Toubai; Nathan D Mathewson; John Magenau; Pavan Reddy
Journal:  Front Immunol       Date:  2016-11-29       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.